Cardiac Surgery Devices Market Size, Share Global Analysis Report, 2026-2034

Industry Insights

[241+ Pages Report] According to Facts & Factors, the global Cardiac Surgery Devices market size was estimated at USD 4.86 billion in 2025 and is expected to reach USD 9.72 billion by the end of 2034. The Cardiac Surgery Devices industry is anticipated to grow by a CAGR of 8.0% between 2026 and 2034. The Cardiac Surgery Devices Market is driven by rising global prevalence of cardiovascular diseases, increasing volume of open-heart and minimally invasive cardiac procedures, and continuous technological advancements in perfusion and beating-heart surgery systems.

Market Overview

The Cardiac Surgery Devices market encompasses a broad range of specialized medical instruments, machines, and disposable products used during open-heart, minimally invasive, and hybrid cardiac surgical procedures. These devices include heart-lung machines and perfusion systems for cardiopulmonary bypass, cardioplegia delivery sets, arterial/venous cannulae, beating-heart stabilization systems (e.g., octopus stabilizers), cardiac ablation probes, valve repair/replacement tools, anastomotic connectors, and endoscopic instruments for minimally invasive approaches. The market supports coronary artery bypass grafting, heart valve repair/replacement, congenital defect correction, aortic aneurysm repair, and atrial fibrillation ablation, serving cardiac surgeons, perfusionists, and operating room teams in hospitals and specialized cardiac centers. It reflects the ongoing evolution from traditional on-pump surgery toward off-pump/beating-heart techniques, robotic-assisted procedures, and hybrid operating room solutions.

Key Insights

• As per the analysis shared by our research analyst, the Cardiac Surgery Devices market is estimated to grow annually at a CAGR of around 8.0% over the forecast period (2026-2034).
• In terms of revenue, the Cardiac Surgery Devices market size was valued at around USD 4.86 billion in 2025 and is projected to reach USD 9.72 billion by 2034.
• The Cardiac Surgery Devices Market is driven by increasing global burden of coronary artery disease, valvular disorders, and rising cardiac surgical volumes in emerging economies.
• Based on the Type, the Perfusion Systems segment dominated the market in 2025 with a share of 34% due to its central role in every on-pump cardiac procedure and continuous innovation in oxygenators and pumps.
• Based on the Application, the Coronary Artery Bypass Grafting segment dominated the market in 2025 with a share of 42%, owing to its position as the most frequently performed open-heart surgery worldwide.
• Based on the End-User, the Hospitals & Cardiac Centers segment dominated the market in 2025 with a share of 86% because complex cardiac surgeries are almost exclusively performed in tertiary hospitals with dedicated cardiac ORs and perfusion teams.
• North America dominated the global Cardiac Surgery Devices market in 2025 with a share of 38%, attributed to high per-capita cardiac surgery rates, advanced hybrid OR adoption, and strong reimbursement for complex cardiac interventions.

Growth Drivers

• Rising Cardiovascular Disease Prevalence & Surgical Volumes

Aging populations, increasing rates of coronary artery disease, valvular heart disease, and heart failure in both developed and emerging markets drive higher demand for CABG, valve repair/replacement, and congenital heart defect surgeries.

Rapid expansion of cardiac surgery capacity in middle-income countries (India, China, Brazil, Turkey) through new dedicated heart hospitals and government-sponsored programs significantly increases annual procedure volumes and device consumption.

Restraints

• Shift Toward Transcatheter & Minimally Invasive Alternatives

Accelerating the adoption of transcatheter aortic valve replacement, MitraClip, percutaneous coronary intervention, and hybrid procedures reduces the need for full open-heart surgery and traditional on-pump devices in many patient groups.

High cost of advanced perfusion systems, beating-heart stabilizers, and disposable cannulae/oxygenators, combined with pricing pressure from hospital procurement groups and public tenders, constrains margin growth for manufacturers.

Opportunities

• Beating-Heart & Off-Pump Surgery Expansion

Growing clinical preference for off-pump CABG and beating-heart techniques in high-risk patients creates demand for specialized stabilizers, shunts, and anastomosis devices that eliminate or minimize cardiopulmonary bypass usage.

Rising hybrid operating room installations and robotic cardiac surgery programs increase the need for compatible endoscopic instruments, perfusion disposables, and integrated monitoring systems tailored to minimally invasive approaches.

Challenges

• Regulatory & Reimbursement Headwinds

Increasingly stringent pre-market clinical evidence requirements for new perfusion systems and beating-heart devices extend development timelines and raise validation costs for manufacturers.

Reimbursement cuts for cardiac surgery procedures in several healthcare systems and bundled payment models push hospitals to favor lower-cost devices, intensifying price competition and margin pressure across the supply chain.

Report Scope

Report Attribute	Details
Market Size 2025	USD 4.86 Billion
Projected Market Size in 2034	USD 9.72 Billion
CAGR Growth Rate	8.0% CAGR
Base Year	2025
Forecast Years	2026-2034
Key Market Players	Medtronic, LivaNova, Getinge, Edwards Lifesciences, Terumo Cardiovascular, Fresenius Medical Care, Cardinal Health, Surge Cardiovascular, Andocor, Qingdao Cardiogood Medical, and Others.
Key Segment	By Type, By Application, By End-User, and By Region
Major Regions Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options	Request customized purchase options to meet your research needs. Explore purchase options

Market Segmentation

The Cardiac Surgery Devices market is segmented by type, application, end-user, and region.

Based on Type Segment, the Cardiac Surgery Devices market is divided into perfusion systems, heart-lung machines, cardiac ablation devices, cardiopulmonary bypass equipment, beating heart surgery systems, and others. The most dominant segment is Perfusion Systems, followed by Cardiopulmonary Bypass Equipment. Perfusion Systems dominate because they are essential for every on-pump cardiac procedure, providing oxygenation, temperature control, and circulation during bypass, with ongoing innovation in oxygenators, pumps, and tubing sets driving replacement and upgrade demand across hospitals globally.

Based on Application Segment, the Cardiac Surgery Devices market is divided into coronary artery bypass grafting, heart valve repair & replacement, congenital heart defect repair, aortic procedures, and others. The most dominant segment is Coronary Artery Bypass Grafting, followed by Heart Valve Repair & Replacement. Coronary Artery Bypass Grafting dominates due to its position as the single most frequently performed open-heart surgery worldwide, requiring the full range of perfusion systems, cannulae, stabilizers, and anastomotic devices, thereby generating the highest and most consistent device volume and revenue.

Based on End-User Segment, the Cardiac Surgery Devices market is divided into hospitals & cardiac centers, ambulatory surgical centers, specialty clinics, and others. The most dominant segment is Hospitals & Cardiac Centers, followed by Ambulatory Surgical Centers. Hospitals & Cardiac Centers dominate overwhelmingly because complex cardiac surgeries requiring advanced perfusion, ablation, and bypass devices are almost exclusively performed in tertiary hospitals and dedicated cardiac surgical units with specialized ORs, perfusion teams, and intensive post-operative care capabilities.

Recent Developments

• In March 2026, Medtronic launched the next-generation Affinity Fusion oxygenator with an integrated arterial filter and improved gas exchange efficiency for adult cardiac surgery.
• In January 2026, LivaNova introduced the Revolution full-flow arterial cannula with a self-inflating fixation balloon and pressure monitoring to reduce embolization risk.
• In November 2025, Getinge (Maquet) released an updated Cardiohelp-i portable heart-lung machine with enhanced monitoring and safety features for hybrid OR and ECMO use.
• In September 2025, Edwards Lifesciences announced FDA clearance for its advanced retrograde cardioplegia delivery system with adjustable flow and an integrated pressure sensor.
• In June 2025, Terumo Cardiovascular expanded its VirtuoSaph Plus endoscopic vein harvesting system with a new low-profile arterial cannula compatible with minimally invasive CABG.

Regional Analysis

• North America to dominate the global market

North America leads the Cardiac Surgery Devices market through the highest per-capita volume of open-heart surgeries, including CABG, valve repair/replacement, and aortic procedures. The region benefits from widespread adoption of advanced perfusion techniques, strong reimbursement for complex cardiac interventions, and the presence of leading device manufacturers with extensive clinical validation networks. Large academic medical centers drive utilization of intra-aortic balloon pumps and ECMO, which also require specialized devices. Continuous innovation in minimally invasive and robotic cardiac surgery further supports premium device demand. The United States dominates within North America owing to its unmatched annual cardiac surgery case volume, most advanced hybrid operating room infrastructure, highest adoption rate of premium perfusion systems and beating-heart devices, and leadership in developing next-generation technologies that set global performance standards.

Europe maintains a very strong position in the Cardiac Surgery Devices market, supported by high-quality universal healthcare systems ensuring broad access to cardiac surgery, a large number of specialized heart centers, a strong focus on myocardial protection during long cross-clamp times, and rigorous post-market surveillance driving continuous product refinement. Germany dominates within Europe through its world-class cardiac surgery outcomes, leadership in perfusion technology and device design, especially pediatric and minimally invasive applications, centralized procurement systems favoring high-quality suppliers, and significant R&D investment in aortic and valve surgery solutions.

Asia Pacific exhibits the fastest growth in the Cardiac Surgery Devices market, driven by rapidly increasing cardiac surgery volumes in China, India, Japan, and South Korea, government investment in new heart hospitals, rising prevalence of coronary and valvular disease, and improving reimbursement for complex procedures. China dominates within Asia Pacific with its explosive growth in cardiac centers, the highest absolute number of new CABG and valve surgeries annually, aggressive localization of device manufacturing, and increasing adoption of premium imported and domestic perfusion and beating-heart systems in tier-1 hospitals.

Latin America shows accelerating growth in the Cardiac Surgery Devices market, fueled by expanding cardiac surgery capacity in Brazil, Mexico, and Argentina, increasing private insurance coverage for heart procedures, and gradual adoption of advanced perfusion techniques in major urban centers. Brazil dominates the region with its large population, the highest regional volume of cardiac surgeries, a growing number of dedicated cardiac hospitals, and a strengthening domestic supply chain for perfusion disposables and cardiac surgery devices.

The Middle East & Africa region demonstrates emerging but promising growth in the Cardiac Surgery Devices market, supported by significant investments in cardiac centers in Gulf countries, medical tourism for complex heart surgeries, and increasing government focus on non-communicable disease management. The United Arab Emirates leads within the region through its world-class cardiac hospitals, high volume of valve and congenital heart surgeries, strong adoption of premium imported devices, and role as a regional hub for advanced cardiac surgery technology deployment.

Competitive Analysis

The global Cardiac Surgery Devices market is dominated by players:

• Medtronic
• LivaNova
• Getinge
• Edwards Lifesciences
• Terumo Cardiovascular
• Fresenius Medical Care
• Cardinal Health
• Surge Cardiovascular
• Andocor
• Qingdao Cardiogood Medical

The global Cardiac Surgery Devices market is segmented as follows:

By Type

• Perfusion Systems
• Heart-Lung Machines
• Cardiac Ablation Devices
• Cardiopulmonary Bypass Equipment
• Beating Heart Surgery Systems
• Others

By Application

• Coronary Artery Bypass Grafting
• Heart Valve Repair & Replacement
• Congenital Heart Defect Repair
• Aortic Procedures
• Others

By End-User

• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America